Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-16-156176

Chief Legal Officer gave up 327 shares (to pay taxes)

  • Chief Legal Officer acquired 1,075 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ali-Jackson Kamil Chief Legal Officer 2016-12-18 Option exercise +1,075 77,032 D: show line 1 in the form
Ali-Jackson Kamil Chief Legal Officer 2016-12-18 Shares withheld for taxes −327 $31.25 $10,219 76,705 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ali-Jackson Kamil Chief Legal Officer 2016-12-18 Option exercise · Restricted Stock Units −1,075 3,225 D: show line 3 in the form
Loading xslF345X03/doc4.xml…